Cimpress Plc CMPR 深 滬
等待開盤 04-17 09:30:00 美东时间
79.18
+0.210
+0.27%
華盛通- 最 高79.99
- 今 開78.27
- 成交量 9.62万股
- 最 低 78.27
- 昨 收 78.97
- 總市值 19.23亿
- 52周最高 82.43
- 市盈率 靜 135.77
- 換手率 0.40%
- 52周最低 35.21
- 委 比 90.48%
- 總股本 2428.52万
- 歷史最高 171.76
- 量 比 0.92
- 振 幅 2.18%
- 歷史最低 18.00
- 每 手 1
- 風險率 12.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cimpress Board Authorizes $200M Buyback Plan With No Expiration Date
https://www.sec.gov/ix?doc=/Archives/edgar/data/1262976/000126297626000009/cmpr-20260325.htm#fact-identifier-4
03-31 20:44
Alpha Buying: Learning From a Research-Driven Hedge Fund
Every now and then a hedge fund manager appears who reminds us that despite all...
03-12 22:31
美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
Cimpress Raises FY2026 Sales Guidance from $3.573B-$3.607B to $3.641B-$3.675B
Cimpress (NASDAQ:CMPR) raises FY2026 sales outlook from $3.573 billion-$3.607 billion to $3.641 billion-$3.675 billion.
01-29 05:22
Cimpress Q2 EPS $1.95 Beats $1.64 Estimate, Sales $1.402B Beat $993.750M Estimate
Cimpress (NASDAQ:CMPR) reported quarterly earnings of $1.95 per share which beat the analyst consensus estimate of $1.64 by 18.9 percent. This is a 17.37 percent decrease over earnings of $2.36 per share from the same
01-29 05:08
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
A Look Ahead: Cimpress's Earnings Forecast
Cimpress (NASDAQ:CMPR) is preparing to release its quarterly earnings on Wednes...
01-28 04:02
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target
Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $83 price target.
01-27 21:10
Cimpress Shareholders Approve 2025 Governance and Capital Measures
Cimpress ( ($CMPR) ) has shared an announcement. On 17 December 2025, Cimpress ...
2025-12-23 05:53
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
